Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+early-stage breast cancer: Phase II CONTROL trial.-MedSci.cn

Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+early-stage breast cancer: Phase II CONTROL trial.

Barcenas, CH; Hurvitz, SA; Di Palma, JA; Bose, R; Chan, A; Chien, AJ; Farrell, C; Hunt, D; McCulloch, L; Kupic, A; Tripathy, D; Rugo, HS

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务